Clinical Trial Update: Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 safety study evaluating allogeneic mesenchymal precursor cells in patients recently experiencing an acute myocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Allogeneic Mesenchymal Precursor Cells (MPCs) (mesenchymal precursor cells)

Snippet

Sponsor: Angioblast Systems | Conditions: Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN